I looked and cannot find anything about why SUPG didn't participate. It's a little strange how SUPG didn't attend conference and also not included in Mogn news on dacogen. Could they be in discussions to be bought out or merging with MOGN? The statment at Mogn analyst meeting was that impairment on SUPG was temporary.